• Japanese
  • Korean
  • Chinese
Cover Image

Lupus Nephritis Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Lupus Nephritis Global Clinical Trials Review, H1, 2015" provides an overview of Lupus Nephritis clinical trials scenario. This report provides top line data relating to the clinical trials on Lupus Nephritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Lupus Nephritis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Lupus Nephritis to Immunology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Lupus Nephritis to Immunology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Lupus Nephritis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Lupus Nephritis Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Lupus Nephritis
      • Mar 30, 2015: Aurinia Highlights Initiation of Its Open Label Clinical Study to Investigate the Impact of Voclosporin on Lupus Nephritis Biomarkers
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Astellas Pharma Inc.
      • Clinical Trial Overview of Astellas Pharma Inc.
      • Biogen, Inc.
      • Clinical Trial Overview of Biogen, Inc.
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • Immune Tolerance Network
      • Clinical Trial Overview of Immune Tolerance Network
      • E. Merck KG
      • Clinical Trial Overview of E. Merck KG
      • Anthera Pharmaceuticals, Inc.
      • Clinical Trial Overview of Anthera Pharmaceuticals, Inc.
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • Aurinia Pharmaceuticals Inc.
      • Clinical Trial Overview of Aurinia Pharmaceuticals Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Nanjing University
      • Clinical Trial Overview of Nanjing University
      • Chinese University of Hong Kong
      • Clinical Trial Overview of Chinese University of Hong Kong
      • National Institute of Arthritis and Musculoskeletal and Skin Diseases
      • Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • All India Institute of Medical Sciences
      • Clinical Trial Overview of All India Institute of Medical Sciences
      • Chulalongkorn University
      • Clinical Trial Overview of Chulalongkorn University
      • Sun Yat-sen University
      • Clinical Trial Overview of Sun Yat-sen University
      • Tuen Mun Hospital
      • Clinical Trial Overview of Tuen Mun Hospital
      • Assistance Publique Hopitaux De Marseille
      • Clinical Trial Overview of Assistance Publique Hopitaux De Marseille
      • Cambridge University Hospitals NHS Foundation Trust
      • Clinical Trial Overview of Cambridge University Hospitals NHS Foundation Trust
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Lupus Nephritis Therapeutics, Global, Clinical Trials by Region, 2015*
  • Lupus Nephritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Lupus Nephritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015*
  • Proportion of Lupus Nephritis to Immunology Clinical Trials, G7 Countries (%), 2015*
  • Lupus Nephritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Lupus Nephritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Lupus Nephritis to Immunology Clinical Trials, E7 Countries (%), 2015*
  • Lupus Nephritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Lupus Nephritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Lupus Nephritis Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Lupus Nephritis Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Lupus Nephritis Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Lupus Nephritis Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Lupus Nephritis Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Lupus Nephritis Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Lupus Nephritis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015*
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen, Inc., 2015*
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Immune Tolerance Network, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Anthera Pharmaceuticals, Inc., 2015*
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Aurinia Pharmaceuticals Inc., 2015*
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Nanjing University, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chulalongkorn University, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tuen Mun Hospital, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique Hopitaux De Marseille, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cambridge University Hospitals NHS Foundation Trust, 2015*

List of Figures

  • Lupus Nephritis Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Lupus Nephritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Lupus Nephritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Lupus Nephritis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Lupus Nephritis Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Lupus Nephritis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
  • Lupus Nephritis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015*
  • Proportion of Lupus Nephritis to Immunology Clinical Trials, G7 Countries (%), 2015*
  • Lupus Nephritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Lupus Nephritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Lupus Nephritis to Immunology Clinical Trials, E7 Countries (%), 2015*
  • Lupus Nephritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Lupus Nephritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Lupus Nephritis Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Lupus Nephritis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Lupus Nephritis Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Lupus Nephritis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Lupus Nephritis Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Lupus Nephritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Show More
Pricing
  • Int'l: +1-860-674-8796
  • TollFree(US): +1-866-353-3335
  • Europe: +32-2-535-7543
  • Asia: +65-6223-2436
Back to Top